Although reported studies have focused on the association between the IRS2 rs1805097(G>A) polymorphism and the risk of colorectal and breast cancer in diverse populations, the results remain inconclusive, partially due to the relatively small sample size in each of the published studies [30]. Here, IRS2 is linked to breast carcinoma.